Skip to main content

Table 3 Odds ratio and corresponding 95%CI for HPV types in dual-stain positive compared to dual-stain negative cases and in HIV positive compared to HIV negative cases, (* significant)

From: Novel concepts in cervical cancer screening: a comparison of VIA, HPV DNA test and p16INK4a/Ki-67 dual stain cytology in Western Kenya

 

Dual-stain cytology

HIV status

HPV 16

* 13.6 (95%CI 4.8–38.6)

0,7 (95%CI 0.2–2.3)

HPV 18

* 26.1 (95%CI 5.8–115.9)

1.2 (95%CI 0.15–9.95)

HPV 31

*8.1 (95%CI 2.1–30.8)

*3 (95%CI 1.1–8.5)

HPV 33

5,6 (95%CI 0.66–48)

*5.1 (95%CI 1.2–20.8)

HPV 35

4.1 (95%CI 0.9–19.1)

*5.1 (95%CI 2.1–12.4)

HPV 39

< 0.00

3.8 (95%CI 0.99–14.7)

HPV 45

4.3 (95%CI 0.92–20.1)

2,7 (95%CI 0.97–7.5)

HPV 51

2,1 (95%CI 0.3–16.7)

*3 (95%CI 1.1–8.5)

HPV 52

2.6 (95%CI 0.6–11.18)

*2.4 (95%CI 1.03–5.8)

HPV 56

< 0.00

< 0.00

HPV 58

*6.6 (95%CI 1.8–24.9)

2 (95%CI 0.7–6)

HPV 59

< 0.00

*4.3 (95%CI 1.1–17.2)

HPV 68

*8 (95%CI 2.7–29.2)

2.3 (95%CI 0.8–6.3)